Clinical trials: suspended, sponsored by Sanofi
Non-cystic Fibrosis Bronchiectasis
A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis
This is a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score at 24 weeks of treatment with SAR445399 compared with placebo in adult participants aged 18 to 80 years with non-cystic…
- Trial name
- NCT07547436
- Testing
- SAR445399
- Where
- 4 sites in United States
- Volunteers
- 70 people
- Sponsor
- Sanofi